Tufton Capital Management’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-16,010
| Closed | -$1.59M | – | 122 |
|
|
2019
Q3 | $1.59M | Sell |
16,010
-1,140
| -7% | -$108K | 0.34% | 61 |
|
|
2019
Q2 | $1.58M | Sell |
17,150
-75
| -0.4% | -$7.12K | 0.34% | 61 |
|
|
2019
Q1 | $1.63M | Buy |
17,225
+132
| +0.8% | +$11.5K | 0.35% | 61 |
|
|
2018
Q4 | $1.09M | Sell |
17,093
-1,134
| -6% | -$83.7K | 0.27% | 70 |
|
|
2018
Q3 | $1.63M | Sell |
18,227
-497
| -3% | -$43.9K | 0.35% | 65 |
|
|
2018
Q2 | $1.49M | Sell |
18,724
-1,014
| -5% | -$84.2K | 0.32% | 68 |
|
|
2018
Q1 | $1.76M | Buy |
19,738
+2,354
| +14% | +$226K | 0.35% | 64 |
|
|
2017
Q4 | $1.81M | Buy |
17,384
+104
| +0.6% | +$11.7K | 0.35% | 64 |
|
|
2017
Q3 | $2.52M | Sell |
17,280
-142
| -0.8% | -$19.3K | 0.5% | 58 |
|
|
2017
Q2 | $2.26M | Buy |
17,422
+2,247
| +15% | +$275K | 0.46% | 60 |
|
|
2017
Q1 | $1.89M | Sell |
15,175
-497
| -3% | -$59.5K | 0.37% | 64 |
|
|
2016
Q4 | $1.81M | Sell |
15,672
-432
| -3% | -$48.1K | 0.37% | 63 |
|
|
2016
Q3 | $1.68M | Sell |
16,104
-37
| -0.2% | -$4K | 0.34% | 68 |
|
|
2016
Q2 | $1.59M | Sell |
16,141
-1,409
| -8% | -$146K | 0.32% | 69 |
|
|
2016
Q1 | $1.76M | Sell |
17,550
-546
| -3% | -$56.2K | 0.44% | 64 |
|
|
2015
Q4 | $2.17M | Sell |
18,096
-1,291
| -7% | -$149K | 0.53% | 58 |
|
|
2015
Q3 | $2.1M | Sell |
19,387
-885
| -4% | -$110K | 0.46% | 65 |
|
|
2015
Q2 | $2.35M | Sell |
20,272
-21,858
| -52% | -$2.5M | 0.47% | 65 |
|
|
2015
Q1 | $4.86M | Buy |
42,130
+120
| +0.3% | +$14.3K | 0.89% | 49 |
|
|
2014
Q4 | $4.7M | Sell |
42,010
-85
| -0.2% | -$8.96K | 0.86% | 53 |
|
|
2014
Q3 | $3.99M | Buy |
42,095
+51
| +0.1% | +$4.6K | 0.75% | 55 |
|
|
2014
Q2 | $3.61M | Buy |
42,044
+344
| +0.8% | +$26.2K | 0.73% | 57 |
|
|
2014
Q1 | $2.91M | Buy |
41,700
+4,988
| +14% | +$395K | 0.61% | 61 |
|
|
2013
Q4 | $3.1M | Sell |
36,712
-7,218
| -16% | -$571K | 0.66% | 58 |
|
|
2013
Q3 | $3.39M | Sell |
43,930
-114
| -0.3% | -$7.99K | 0.8% | 51 |
|
|
2013
Q2 | $2.58M | Buy |
+44,044
| New | +$2.65M | 0.62% | 62 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Tufton Capital Management's CELG Position: Q4 2019 in Review
Tufton Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 16,010 shares — an estimated $1.59M sold.
Tufton Capital Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $4.86M in Q1 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Tufton Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Tufton Capital Management sold 16,010 Celgene Corp shares in Q4 2019, an estimated $1.59M.
- Tufton Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Tufton Capital Management's Celgene Corp position peaked at $4.86M in Q1 2015.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Tufton Capital Management's 13F filing for Q4 2019, filed 24 Jan 2020.